These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27045030)

  • 1. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy.
    He B; Zhao YC; Gao LC; Ying XY; Xu LW; Su YY; Ji QQ; Lin N; Pu J
    Hypertension; 2016 Jun; 67(6):1237-48. PubMed ID: 27045030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling.
    Ying X; Zhao Y; Yao T; Yuan A; Xu L; Gao L; Ding S; Ding H; Pu J; He B
    Hypertension; 2016 Nov; 68(5):1160-1170. PubMed ID: 27572150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
    Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
    Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
    J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of USP22 alleviates cardiac hypertrophy induced by pressure overload through HiF1-α-TAK1 signaling pathway.
    Jiang YN; Yang SX; Guan X; Chen Q; Zhao L; Yu XY; Ren FF; Wu SJ; Wu LP; Lai TF; Li L
    Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166813. PubMed ID: 37488049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
    Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
    Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling.
    Huang Z; Shu J; Jiang W; Jiang M; Lu Y; Dai H; Xu N; Yuan H; Cai J
    J Am Heart Assoc; 2018 Oct; 7(19):e009179. PubMed ID: 30371330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload.
    Jiang DS; Li L; Huang L; Gong J; Xia H; Liu X; Wan N; Wei X; Zhu X; Chen Y; Chen X; Zhang XD; Li H
    Hypertension; 2014 Jul; 64(1):77-86. PubMed ID: 24732887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
    Li CY; Zhou Q; Yang LC; Chen YH; Hou JW; Guo K; Wang YP; Li YG
    Basic Res Cardiol; 2016 Mar; 111(2):19. PubMed ID: 26891723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
    Lu P; Xu Y; Sheng ZY; Peng XG; Zhang JJ; Wu QH; Wu YQ; Cheng XS; Zhu K
    Exp Cell Res; 2021 Sep; 406(1):112761. PubMed ID: 34339675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of Circulating MFGE8 (Milk Fat Globule-EGF Factor 8) Attenuates Cardiac Hypertrophy Through Inhibition of Akt Pathway.
    Deng KQ; Li J; She ZG; Gong J; Cheng WL; Gong FH; Zhu XY; Zhang Y; Wang Z; Li H
    Hypertension; 2017 Oct; 70(4):770-779. PubMed ID: 28827473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice.
    Zhao Y; Wang F; Gao L; Xu L; Tong R; Lin N; Su Y; Yan Y; Gao Y; He J; Kong L; Yuan A; Zhuge Y; Pu J
    Hepatology; 2018 Sep; 68(3):897-917. PubMed ID: 29573006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor β-Activated Kinase 1-Dependent Signaling Pathways.
    Chen L; Huang J; Ji YX; Mei F; Wang PX; Deng KQ; Jiang X; Ma G; Li H
    Hypertension; 2017 Feb; 69(2):249-258. PubMed ID: 27956576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.
    Miao R; Lu Y; Xing X; Li Y; Huang Z; Zhong H; Huang Y; Chen AF; Tang X; Li H; Cai J; Yuan H
    Hypertension; 2016 Jan; 67(1):86-98. PubMed ID: 26573707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deubiquitinase Ubiquitin-Specific Protease 10 Deficiency Regulates Sirt6 signaling and Exacerbates Cardiac Hypertrophy.
    Zhang DH; Zhang JL; Huang Z; Wu LM; Wang ZM; Li YP; Tian XY; Kong LY; Yao R; Zhang YZ
    J Am Heart Assoc; 2020 Nov; 9(22):e017751. PubMed ID: 33170082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.
    Liu J; Liu X; Hui X; Cai L; Li X; Yang Y; Shu S; Wang F; Xia H; Li S
    J Am Heart Assoc; 2019 Aug; 8(16):e011830. PubMed ID: 31426686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
    Jiang X; Deng KQ; Luo Y; Jiang DS; Gao L; Zhang XF; Zhang P; Zhao GN; Zhu X; Li H
    Hypertension; 2015 Aug; 66(2):356-67. PubMed ID: 26034202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.
    Xu Z; Mei F; Liu H; Sun C; Zheng Z
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SENP1 Protects Against Pressure Overload-Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling.
    Yang D; Fan D; Guo Z; Liu FY; Wang MY; An P; Yang Z; Tang QZ
    J Am Heart Assoc; 2022 Nov; 11(22):e027004. PubMed ID: 36370010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.